Background: The authors evaluated the effect of carotid artery stenting (CAS) on ocular circulation and chronic ocular ischemic syndrome. Methods: We examined 38 patients with carotid artery stenosis (>80%) at its origin treated with CAS. Ocular circulation and symptoms were examined before, within 24 h, and 1 week, 1 month, and 3 months after CAS based on ophthalmic artery color Doppler flow imaging and ophthalmological examinations. Results: Ocular circulation: Before CAS, 13 patients showed reversed ophthalmic artery flow, and 25 antegrade flow. Average peak systolic flow velocity was –0.038 m/s. Within 24 h after CAS, all patients showed antegrade ophthalmic artery flow; reversed flow before CAS was thus resolved. Average peak systolic flow velocity rose significantly to 0.36 m/s (p < 0.05). One week, 1 month and 3 months after CAS, there were no significant changes compared to the findings at 1 week after CAS. Ocular symptoms: Before CAS, 8 patients showed chronic ocular ischemic syndrome. During the follow-up period (mean: 2.8 years), the visual acuity improved in 7 cases. Average retinal artery pressure and arm-to-retina circulation time improved significantly to the normal level (p < 0.05). The other 30 patients complained of recurrent and worsened visual symptoms during the follow-up period. Conclusion: CAS was effective in improving ocular circulation, and also improved the chronic ocular ischemic syndrome caused by the severe carotid artery stenosis.

Keywords:
Carotid artery stenting, Chronic ocular ischemic syndrome, Color Doppler flow imaging, Ophthalmic artery flow
1.
Asymptomatic carotid atherosclerosis study, executive committee: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421–1428.
2.
European Carotid Surgery Trialist’s Collaborative Group: European carotid surgery trial: Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991;337:1235–1243.
3.
Mayberg MR, Winn HR: Carotid endarterectomy for asymptomatic stenosis: Controversy resolved. JAMA 1995;273:1459–1459.
4.
North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445–453.
5.
Powell RJ, Schermerhorn M, Nolan B, Lenz J, Rzuidlo E, Fillinger M, Walsh D, Wyers M, Zwolak R, Cronenwett JL: Early results of carotid stent placement for treatment of extracranial carotid bifurcation occlusive disease. J Vasc Surg 2004;39:1193–1199.
6.
Roubin GS, New G, Iyer SS, Vitek JJ, Al-Mubarak N, Liu MW, Yadav J, Gomez C, Kuntz RE: Immediate and late clinical outcomes of carotid artery stenting in symptomatic and asymptomatic carotid stenosis: a 5-year prospective analysis. Circulation 2001;103:532–537.
7.
Wholey MH, Eles G: Cervical carotid artery stent placement. Semin Inter Cardiol 1998;3:105–115.
8.
Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Oureil K: Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–1501.
9.
Shawl F, Kadro W, Domanski MJ, Lapetina FL, Iqbal AA, Dougherty KG, Weisher DD, Marquez JF, Shahab ST: Safety and efficacy of elective carotid artery stenting in high-risk patients. J Am Coll Cardiol 2000;35:1721–1728.
10.
Wholey MH, Wholey M, Mathias K, Roubin GS, Diethrich EB, Henry M, Bailey S, Bergeron P, Dorros G, Eles G, Gaines P, Gomez CR, Gray B, Guimaraens J, Higashida R, Ho DS, Katzen B, Kambara A, Kumar V, Laborde JC, Leon M, Lim M, Londero H, Mesa J, Musacchio A, Myla S, Ramee S, Rodriquez A, Rosenfield K, Sakai N, Shawl F, Sievert H, Teitelbaum G, Theron JG, Vaclav P, Vozzi C, Yadav JS, Yoshimura SI: Global experience in cervical carotid stent placement. Cather Cardiovasc Interv 2000;50:160–167.
11.
Costa VP, Kuzniec S, Molnar L, Cerri GG, Puech-Leao P, Carvalho CA: Clinical findings and hemodynamic changes associated with severe occlusive carotid artery disease. Ophthalmology 1997;104:1994–2002.
12.
Young LHY, Appen RE: Ischemic oculopathy. A manifestation of carotid artery disease. Arch Neurol 1981;38:358–361.
13.
Mizener JB, Podhajky P, Hayreh SS: Ocular ischemic syndrome. Ophthalmology 1997;104:859–864.
14.
Riihelanen K, Paivansalo M, Suramo I, Laatikainen L: The effect of carotid endarterectomy on ocular blood velocity. Ophthalmology 1997;104:672–675.
15.
Kawaguchi S, Okuno S, Sakaki T, Nishikawa N: Effect of carotid endarterectomy on chronic ocular ischemic syndrome due to internal carotid artery stenosis. Neurosurgery 2001;48:328–333.
16.
Kawaguchi S, Sakaki T, Uraniahsi R, Iida Y: Effect of carotid endarterectomy on the ophthalmic artery. Acta Neurochir (Wien) 2002;144:427–432.
17.
Onizuka M, Matsuya N, Miyazaki H: Placement of stent for internal carotid artery stenosis in the cervical portion improved ocular ischemic syndrome. Brain and Nerve 2001;53:679–682.
18.
Whileta JR, Chati Z, Krafft V, Amor M: Retinal embolization during carotid artery angioplasty and stenting: Mechanisms and role of cerebral protection systems. Cather Cardiovasc Interv 2002;56:320–327.
19.
Countee RW, Vijayanathan T: External carotid artery in internal carotid artery occlusion. Angiographic, therapeutic, and prognostic considerations. Stroke 1979;10:450–459.
20.
Hu HH, Wang S, Chern CM, Yeh HH, Sheng WY, Lo YK: Clinical significance of the ophthalmic artery in carotid artery disease. Acta Neurol Scand 1995;92:242–246.
21.
Costa VP, Kuzniec S, Molnar L, Cerri GG, Puech-Leao P, Carvalho CA: Clinical findings and hemodynamic changes associated with severe occlusive carotid artery disease. Ophthalmology 1997;104:1994–2002.
22.
Hu HH, Sheng WY, Yen MY, Lai ST, Teng MMH: Color Doppler imaging of orbital arteries for detection of carotid occlusive disease. Stroke 1993;24:1196–1203.
23.
McCabe DJH, Brown MM, Clifton A: Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke 1990;30:2483–2486.
24.
Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, Halback VV: Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery 2000;47:335–345.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.